Code	Sector	Market
130A	Pharmaceuticals	Growth

Date of listing approval	2024/01/05
Expected Date	2024/02/08
Lead Underwriter	Mizuho
Description

Listed Shares(total)	920,000
Trading Unit	100
New Shares	800,000
Existing Shares	120,000（only O.A.）
Shares Outstanding	PreIPO 5,501,314.00
	PostIPO 6,301,314.00
Paid Up Capital	PreIPO Y90,000,000
	PostIPO Y312,548,000
Expected Pricing Date	2024/01/23
Book Building Start	2024/01/24
Book Building End	2024/01/30
Fix Date	2024/01/31
Offering Starts	2024/02/01
Offering Ends	2024/02/06
Expect Pricing	Y800-Y1,000
Notional PER (based on previous period)	-31.13--38.91
Notional PER(based on results forecast)	141.09-176.37
Offering Price	Y1,000
Offering Price PER (based on previous period)	141.09-176.37
Offering Price PBR (based on previous period)	3.57
Offering Price PER (based on results forecast)	176.37
Use of Funds Raised

Units:Y1,000

Fiscal Year End:2020/12
	Consolidated	Non-consolidated
Revenue	-	13,326
Current Profit	-	-297,034
Net Profit	-	-297,905
Net Assets	-	516,291

Fiscal Year End:2021/12
	Consolidated	Non-consolidated
Revenue	-	59,330
Current Profit	-	-240,082
Net Profit	-	-232,319
Net Assets	-	1,683,971

Fiscal Year End:2022/12
	Consolidated	Non-consolidated
Revenue	-	178,801
Current Profit	-	-138,455
Net Profit	-	-141,381
Net Assets	-	1,542,590

Recent Quarter 2023/09
	Consolidated	Non-consolidated
Revenue	-	279,251
Current Profit	-	37,888
Net Profit	-	35,750
Net Assets	-	1,578,341

Results Forecast 2023/12
	Consolidated	Non-consolidated
Revenue	-	359,000
Current Profit	-	34,000
Net Profit	-	31,000
Net Assets	-	-

Per Share Units:Y1

Fiscal Year End:2020/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-68.00	117.84

Fiscal Year End:2021/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-51.92	306.10

Fiscal Year End:2022/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-25.70	280.40

Fiscal Year End:Recent Quarter 2023/09
	Consolidated	Non-consolidated
Dividend
Net Earning	-	6.50
Equity	-	-

Fiscal Year End:Results Forecast 2023/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	5.67
Equity	-	-

■Over allotment(120,000）

Name	Address

Allocation	Underwriter	Tel
0%	Nomura	03-3211-1811
93.3%	Mizuho	03-5208-3210
2%	SMBC Nikko	03-5644-3111
2%	Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.	03-6213-8500
1.1%	Rakuten Securities	03-6406-2681
1.1%	Matsui	03-5216-0606
0.5%	Akatsuki Securities	03-5641-7800